YELESWARAM KRISHNASWAMY (Chief Development Officer) sold 0.2% of their position (404.00 shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $20.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2026ACC: 0001193125-26-359189
Officer· Chief Development Officer
Since Feb 2026
-404.00
Net shares
Net seller
$20.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
404.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−404.00
Price / share
$49.90
Trade value
$20.16K
% of position
0.2%
8/19/2026
246.43K→246.02K
Total
Net shares
−404.00
Net value
-$20.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/19/2026 | S · Sale | −404.00 | $49.90 | $20.16K | 0.2% | 246.43K | 246.02K |
| Total | −404.00 | -$20.16K | ||||||
Derivative Transactions0
No derivative transactions reported